logo

For the Inventor, By the Inventor

Enfield, CT, United States of America

David F Bruton

This inventor holds 9 USPTO granted patents and 4 published patent applications. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Other. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David F Bruton. Retrieved from https://idiyas.com/inventor/david-f-bruton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 8

Forward Citations = 301(Granted Patents)


Company Filing History:

goldMedal7 out of 826 
 
Abbvie Inc.
 patents
silverMedal1 out of 4,187 
 
Abbott Laboratories Corporation
 patents
bronzeMedal1 out of 834,453 
Other
 patents

Years Active: 2012-2018

Loading Chart...
9 patents (USPTO):Explore Patents
1. 10119118 - Modified serum-free cell culture medium (2018-11-06),
2. 9284371 - Methods of producing adalimumab (2016-03-15),
3. 9234032 - Fed-batch methods for producing adalimumab (2016-01-12),
4. 9090867 - Fed-batch method of making anti-TNF-alpha antibody (2015-07-28),
5. 9073988 - Fed batch method of making anti-TNF-alpha antibodies (2015-07-07),
6. 8911964 - Fed-batch method of making human anti-TNF-alpha antibody (2014-12-16),
7. 8906646 - Fed-batch method of making human anti-TNF-alpha antibody (2014-12-09),
8. 8663945 - Methods of producing anti-TNF-alpha antibodies in mammalian cell culture (2014-03-04),
9. 8093045 - Fed-batch cell culture methods using non-animal-based hydrolysates (2012-01-10),

Title: David F Bruton: Innovator in Cell Culture Technology

Introduction

David F Bruton is a notable inventor based in Enfield, CT (US), recognized for his contributions to the field of cell culture technology. With a total of 9 patents, he has made significant advancements in the production of recombinant proteins, particularly antibodies, in mammalian cell cultures.

Latest Patents

Among his latest patents, Bruton has developed a modified serum-free cell culture medium. This invention describes improved methods and compositions for producing recombinant proteins, such as antibodies, in mammalian cell culture. Additionally, it provides enhanced cell culture media, including production media, feed solutions, and combination feeds, aimed at improving protein productivity in mammalian cell culture. Another significant patent focuses on methods of producing adalimumab, further showcasing his expertise in optimizing recombinant protein production.

Career Highlights

Bruton has had a distinguished career, working with prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the biotechnology sector.

Collaborations

Throughout his career, Bruton has collaborated with talented individuals, including Itzcoatl A Pla and John C Fann. These partnerships have fostered a collaborative environment that has led to the development of innovative solutions in cell culture technology.

Conclusion

David F Bruton stands out as a key figure in the field of cell culture technology, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing biotechnology. His work continues to influence the production of recombinant proteins, making a lasting impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…